Home » Medicatie – Themapagina » Plenadren – verdiepingsartikel » Onderzoek naar het gebruik van Plenadren Artikelen Artikel Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial (Andrea M Isidori*, Mary Anna Venneri*, Chiara Graziadio, Chiara Simeoli, Daniela Fiore, Valeria Hasenmajer et al. The Lancet 2017; december 8 published online). Gerelateerde artikelen Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency – Authors’ reply Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency Onderzoek Plendren
